Literature DB >> 33692794

T Cell Protein Tyrosine Phosphatase in Osteoimmunology.

Ya-Nan Wang1,2,3, Shiyue Liu2,3,4, Tingting Jia1,2,3, Yao Feng1,2,3, Wenjing Zhang1,2,3, Xin Xu1,2,3, Dongjiao Zhang1,2,3.   

Abstract

Osteoimmunology highlights the two-way communication between bone and immune cells. T cell protein tyrosine phosphatase (TCPTP), also known as protein-tyrosine phosphatase non-receptor 2 (PTPN2), is an intracellular protein tyrosine phosphatase (PTP) essential in regulating immune responses and bone metabolism via dephosphorylating target proteins. Tcptp knockout in systemic or specific immune cells can seriously damage the immune function, resulting in bone metabolism disorders. This review provided fresh insights into the potential role of TCPTP in osteoimmunology. Overall, the regulation of osteoimmunology by TCPTP is extremely complicated. TCPTP negatively regulates macrophages activation and inflammatory factors secretion to inhibit bone resorption. TCPTP regulates T lymphocytes differentiation and T lymphocytes-related cytokines signaling to maintain bone homeostasis. TCPTP is also expected to regulate bone metabolism by targeting B lymphocytes under certain time and conditions. This review offers a comprehensive update on the roles of TCPTP in osteoimmunology, which can be a promising target for the prevention and treatment of inflammatory bone loss.
Copyright © 2021 Wang, Liu, Jia, Feng, Zhang, Xu and Zhang.

Entities:  

Keywords:  B cell; Protein tyrosine phosphatase non-receptor 2 (PTPN2); T cell; T cell protein tyrosine phosphatase (TCPTP); macrophages; osteoimmunology

Mesh:

Substances:

Year:  2021        PMID: 33692794      PMCID: PMC7938726          DOI: 10.3389/fimmu.2021.620333

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  114 in total

1.  Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells.

Authors:  Jiang Zhu; Russell Garrett; Younghun Jung; Yi Zhang; Nacksung Kim; Jingcheng Wang; Gerard J Joe; Elizabeth Hexner; Yongwon Choi; Russell S Taichman; Stephen G Emerson
Journal:  Blood       Date:  2007-01-16       Impact factor: 22.113

2.  Characterization of PTPN2 and its use as a biomarker.

Authors:  Stéphanie Bussières-Marmen; Andrew P Hutchins; Anja Schirbel; Nancy Rebert; Tony Tiganis; Claudio Fiocchi; Diego Miranda-Saavedra; Michel L Tremblay
Journal:  Methods       Date:  2013-08-30       Impact factor: 3.608

3.  Modulation of STAT3 phosphorylation by PTPN2 inhibits naïve pluripotency of embryonic stem cells.

Authors:  Yan Zhang; Huiwen Ding; Xiaohu Wang; Shou-Dong Ye
Journal:  FEBS Lett       Date:  2018-06-08       Impact factor: 4.124

Review 4.  Interleukin-17 and type 17 helper T cells.

Authors:  Pierre Miossec; Thomas Korn; Vijay K Kuchroo
Journal:  N Engl J Med       Date:  2009-08-27       Impact factor: 91.245

5.  The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3.

Authors:  Paul D Simoncic; Ailsa Lee-Loy; Dwayne L Barber; Michel L Tremblay; C Jane McGlade
Journal:  Curr Biol       Date:  2002-03-19       Impact factor: 10.834

6.  T Cells Are Required for Orthodontic Tooth Movement.

Authors:  Y Yan; F Liu; X Kou; D Liu; R Yang; X Wang; Y Song; D He; Y Gan; Y Zhou
Journal:  J Dent Res       Date:  2015-07-17       Impact factor: 6.116

7.  The JAK Inhibitor Tofacitinib Rescues Intestinal Barrier Defects Caused by Disrupted Epithelial-macrophage Interactions.

Authors:  Marianne R Spalinger; Anica Sayoc-Becerra; Christ Ordookhanian; Vinicius Canale; Alina N Santos; Stephanie J King; Moorthy Krishnan; Meera G Nair; Michael Scharl; Declan F McCole
Journal:  J Crohns Colitis       Date:  2021-03-05       Impact factor: 9.071

8.  Novel small molecule IL-6 inhibitor suppresses autoreactive Th17 development and promotes Treg development.

Authors:  S I Aqel; E E Kraus; N Jena; V Kumari; M C Granitto; L Mao; M F Farinas; E Y Zhao; G Perottino; W Pei; A E Lovett-Racke; M K Racke; J R Fuchs; C Li; Y Yang
Journal:  Clin Exp Immunol       Date:  2019-01-24       Impact factor: 4.330

Review 9.  Protein tyrosine phosphatases in lymphocyte activation and autoimmunity.

Authors:  Inmoo Rhee; André Veillette
Journal:  Nat Immunol       Date:  2012-04-18       Impact factor: 25.606

10.  Identification of a nuclear Stat1 protein tyrosine phosphatase.

Authors:  Johanna ten Hoeve; Maria de Jesus Ibarra-Sanchez; Yubin Fu; Wei Zhu; Michel Tremblay; Michael David; Ke Shuai
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.